← F&G Annuities & Life, Inc.
| Annual Trend | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Net earnings (loss) | $865.0m | $481.0m | ($58.0m) | $642.0m | $271.0m | |
| Depreciation and amortization | $484.0m | $329.0m | $412.0m | $569.0m | $665.0m | |
| (Gain) loss on sales of investments and other assets and asset impairments, net | ($576.0m) | $436.0m | $461.0m | ($210.0m) | $128.0m | |
| Interest credited/index credits to contractholder account balances | $804.0m | ($542.0m) | $1.4b | $1.3b | $202.0m | |
| Change in market risk benefits, net | ($44.0m) | ($182.0m) | $95.0m | ($25.0m) | $167.0m | |
| Deferred policy acquisition costs and deferred sales inducements | ($675.0m) | ($814.0m) | ($1.1b) | ($1.4b) | ($1.3b) | |
| Charges assessed to contractholders for mortality and administration | ($180.0m) | ($212.0m) | ($255.0m) | ($291.0m) | ($330.0m) | |
| Distributions from unconsolidated affiliates, return on investment | $70.0m | $119.0m | $104.0m | $108.0m | $176.0m | |
| Stock-based compensation cost | $9.0m | $12.0m | $23.0m | $29.0m | $31.0m | |
| Change in NAV of limited partnerships, net | ($589.0m) | ($109.0m) | ($220.0m) | ($350.0m) | ($349.0m) | |
| Change in valuation of derivatives, equity and preferred securities and other assets, net | ($140.0m) | $561.0m | ($347.0m) | $60.0m | ($144.0m) | |
| Change in reinsurance recoverable | $94.0m | $21.0m | $94.0m | ($19.0m) | ($5.0m) | |
| Change in derivative collateral liabilities | — | ($398.0m) | $410.0m | $91.0m | $249.0m | |
| Change in future policy benefits | $634.0m | $1.2b | $1.3b | $1.9b | $1.7b | |
| Change in funds withheld from reinsurers | $850.0m | $2.1b | $3.4b | $3.8b | $3.3b | |
| Net change in income taxes | $138.0m | $170.0m | ($4.0m) | $103.0m | $22.0m | |
| Net change in other assets and other liabilities | $69.0m | ($528.0m) | $491.0m | ($264.0m) | ($103.0m) | |
| Additions to property and equipment and capitalized software | ($33.0m) | ($32.0m) | ($27.0m) | ($24.0m) | ($15.0m) | |
| Other acquisitions/disposals, net of cash acquired | ($43.0m) | $0 | $0 | ($482.0m) | $0 | |
| Additional investments in unconsolidated affiliates | ($1.7b) | ($982.0m) | ($1.1b) | ($1.1b) | ($2.4b) | |
| Net increase in policy loans | — | ($13.0m) | ($19.0m) | ($33.0m) | ($43.0m) | |
| Distributions from unconsolidated affiliates, return of investment | $150.0m | $313.0m | $340.0m | $478.0m | $694.0m | |
| Net change in notes receivable | — | $0 | $0 | ($13.0m) | ($10.0m) | |
| Borrowings | $400.0m | $550.0m | $845.0m | $1.1b | $375.0m | |
| Payment of contingent consideration for acquisitions | — | — | $0 | $0 | ($10.0m) | |
| Net revolving credit facility (repayments) borrowings | $0 | $0 | ($185.0m) | ($365.0m) | $0 | |
| Purchases of treasury stock | $0 | $0 | ($18.0m) | ($12.0m) | ($10.0m) | |
| Issuance of preferred stock | — | $0 | $0 | $250.0m | $0 | |
| Contractholder account deposits | $8.2b | $8.5b | $7.8b | $10.1b | $11.6b | |
| Contractholder account withdrawals | ($2.9b) | ($3.5b) | ($4.6b) | ($8.0b) | ($8.8b) | |
| Net cash provided by operating activities | $1.9b | $3.2b | $5.8b | $6.0b | $4.7b | |
| Purchases of investment securities | ($14.6b) | ($12.4b) | ($13.3b) | ($16.9b) | ($22.5b) | |
| Net proceeds from sales, maturities and purchases of short-term investment securities | $71.0m | ($1.7b) | ($28.0m) | ($1.1b) | $1.5b | |
| Proceeds from sales, calls and maturities of investments | $9.3b | $5.4b | $5.3b | $11.3b | $14.3b | |
| Net cash used in investing activities | ($6.9b) | ($9.4b) | ($8.9b) | ($8.0b) | ($8.4b) | |
| Debt issuance costs | $0 | ($4.0m) | ($16.0m) | ($20.0m) | ($11.0m) | |
| Repayments of outstanding debt | — | $0 | $0 | ($250.0m) | ($300.0m) | |
| Issuance of common stock | — | — | $0 | $0 | $269.0m | |
| Dividends paid | $0 | $0 | ($101.0m) | ($121.0m) | ($137.0m) | |
| Dividends and distributions paid to non-controlling interest shareholders | — | $0 | $0 | ($14.0m) | ($18.0m) | |
| Net cash provided by (used in) financing activities | $5.6b | $5.6b | $3.7b | $2.7b | $3.0b | |
| Net (decrease) increase in cash and cash equivalents | $644.0m | ($573.0m) | $603.0m | $701.0m | ($778.0m) | |
| Cash and cash equivalents at beginning of period | $1.5b | $960.0m | $1.6b | $2.3b | $1.5b |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.